Based on the Canopy Growth Corp stock forecast from 1 analysts, the average analyst target price for Canopy Growth Corp is USD 2.00 over the next 12 months. Canopy Growth Corp’s average analyst rating is Sell. Stock Target Advisor’s own stock analysis of Canopy Growth Corp is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Canopy Growth Corp’s stock price was USD 3.90. Canopy Growth Corp’s stock price has changed by +4.56% over the past week, -20.57% over the past month and -30.12% over the last year.
No recent analyst target price found for Canopy Growth Corp
No recent average analyst rating found for Canopy Growth Corp
Company Overview Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada. Read Less
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada ...Read More
Frequently Asked Questions About Canopy Growth Corp (CGC) Stock
Unfortunately we do not have enough data on CGC's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CGC is USD 2.00 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 2.
CGC stock's Price/Earning ratio is 67.17.
Our analysis grades CGC stock's Price / Earning ratio at F. This means that CGC stock's Price/Earning ratio is above 80% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this CGC may be a overvalued for its sector.
The last closing price of CGC's stock was USD 3.90.
The most recent market capitalization for CGC is USD 0.49B.
Based on targets from 1 analysts, the average taret price for CGC is projected at USD 2.00 over the next 12 months.
This means that CGC's stock price may go down by -48.72% over the next 12 months.
We can't find any ETFs which contains Canopy Growth Corp's stock.
As per our most recent records Canopy Growth Corp has 1,029 Employees.
Canopy Growth Corp's registered address is 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8.
You can get more information about it from Canopy Growth Corp's website at https://www.canopygrowth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Frequently Asked Questions About Canopy Growth Corp (CGC) Stock
Unfortunately we do not have enough data on CGC's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for CGC is USD 2.00 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 2.
CGC stock's Price/Earning ratio is 67.17.
Our analysis grades CGC stock's Price / Earning ratio at F. This means that CGC stock's Price/Earning ratio is above 80% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this CGC may be a overvalued for its sector.
The last closing price of CGC's stock was USD 3.90.
The most recent market capitalization for CGC is USD 0.49B.
Based on targets from 1 analysts, the average taret price for CGC is projected at USD 2.00 over the next 12 months.
This means that CGC's stock price may go down by -48.72% over the next 12 months.
We can't find any ETFs which contains Canopy Growth Corp's stock.
As per our most recent records Canopy Growth Corp has 1,029 Employees.
Canopy Growth Corp's registered address is 1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8.
You can get more information about it from Canopy Growth Corp's website at https://www.canopygrowth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CGC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
